Tanvex Biopharma, Inc.TWSE: 6541

Announcement of the Resolution of Annual General Meeting to Approve of Lifting of Non-Competition Restrictions for Board Director.

· Issued by Tanvex BioPharma, Inc.
Close
Today's Information

Provided by: Tanvex BioPharma, Inc.
SEQ_NO 5 Date of announcement 2022/06/17 Time of announcement 19:39:01
Subject
 Announcement of the Resolution of Annual General
Meeting to Approve of Lifting of Non-Competition
Restrictions for Board Director.
Date of events 2022/06/17 To which item it meets paragraph 21
Statement
1.Date of the shareholders meeting resolution:2022/06/17
2.Name and title of the director with permission to engage in competitive
  conduct:
Yen, Yun/Director
Chen, Chi-Chuan/Director
Tseng, Tamon/Director
Allen Chao/Director
David Hsia/Director
Xue, Ula/Director
Tsai, Jin-Pau/Independent Director
Wang, Tay-hang/Independent Director
3.Items of competitive conduct in which the director is permitted to engage:
To engage in business that are identical or similar to the business scope of
Tanvex
4.Period of permission to engage in the competitive conduct:
During the period of employment as independent directors of the company.
5.Circumstances of the resolution (please describe the results of voting in
accordance with Article 209 of the Company Act):
The votes in favor of the total represented share is 85.11%, and hereby
was approved as proposed.
6.If the permitted competitive conduct belongs to the operator of a mainland
China area enterprise, the name and title of the directors
(if it is not the operator of a Mainland-area enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China area enterprise and the director's
position in the enterprise:N/A
8.Address of the mainland China area enterprise:N/A
9.Operations of the mainland China area enterprise:N/A
10.Impact on the company's finance and business:None
11.If the directors have invested in the mainland China area enterprise,
the monetary amount of the investment and their shareholding ratio:N/A
12.Any other matters that need to be specified:None

Company analysis

Earlier from Tanvex Biopharma

All Tanvex Biopharma news releases